Abstract
The multifactorial nature of chronic pain with its numerous comorbidities presents a formidable challenge in disentangling their aetiology. Here, we performed genome-wide association studies of eight regional chronic pain types using UK Biobank data (N=4,037–79,089 cases; N=239,125 controls), followed by bivariate linkage disequilibrium-score regression and latent causal variable analyses to determine (respectively) their genetic correlations and genetic causal proportion (GCP) parameters with 1,492 other complex traits. We report evidence of a shared genetic signature across common chronic pain types as their genetic correlations and GCP parameter directions were broadly consistent across a wide array of biopsychosocial traits. Across 5,942 significant genetic correlations, 570 trait pairs could be explained by a causal association (|GCP| > 0.6; 5% false discovery rate), including 82 traits affected by pain while 488 contributed to an increased risk of chronic pain such as certain somatic pathologies (e.g., musculoskeletal), psychiatric traits (e.g., depression), socioeconomic factors (e.g., occupation) and medical comorbidities (e.g., cardiovascular disease). This data-driven study has demonstrated a novel & efficient strategy for identifying genetically supported risk & protective traits to enhance the design of interventional trials targeting underlying causal factors and help accelerate the development of more effective treatments with broader clinical utility.
Competing Interest Statement
GC-P contributed to this study while employed at The University of Queensland. He is now an employee of 23andMe, Inc and may hold stock in the company.
Funding Statement
AIC was supported by a UQ Research Training Scholarship from The University of Queensland. PFK was supported by an Australian Government Research Training Program Scholarship from Queensland University of Technology (QUT). RECOVER Injury Research Centre (MS, SFF) receives unrestricted grant funding from the Motor Accident Insurance Commission (Queensland). The funders had no role in the design or interpretation of this study. This research was initially carried out at the Translational Research Institute (TRI), Woolloongabba, QLD 4102, Australia. TRI is supported by a grant from the Australian Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Complex trait GWAS summary statistics are publicly available. Links to reference and download each of these are available in CTG-VL (https://vl.genoma.io) and CTG-VIEW (https://view.genoma.io). Complete GWAS summary statistics and results from downstream analyses for all the chronic pain types reported in the current study (Supplementary Table S1) are available at CTG-VIEW.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures: AIC was supported by a UQ Research Training Scholarship from The University of Queensland. PFK was supported by an Australian Government Research Training Program Scholarship from Queensland University of Technology (QUT). RECOVER Injury Research Centre (MS, SFF) receives unrestricted grant funding from the Motor Accident Insurance Commission (Queensland). The funders had no role in the design or interpretation of this study. This research was initially carried out at the Translational Research Institute (TRI), Woolloongabba, QLD 4102, Australia. TRI is supported by a grant from the Australian Government. SFF, TTN & GC-P conceived the study. TTN & GC-P co-supervised the study. SFF & TTN performed the literature search. AIC & MER performed the GWAS. SFF & ML performed downstream analyses with support from GC-P. SFF prepared the figures with support from TTN & GC-P. All authors contributed to interpretation of results. SFF, TTN & GC-P wrote the manuscript with feedback from all coauthors. GC-P contributed to this study while employed at The University of Queensland. He is now an employee of 23andMe, Inc and may hold stock in the company. The other authors have no conflicts of interest to declare.
This version has been updated to reflect revisions to the text (primarily Abstract, Introduction, Discussion, supplementary file). The data comprising the actual results have not changed. An additional author has been added.
Data Availability
Complex trait GWAS summary statistics are publicly available. Links to reference and download each of these are available in CTG-VL (https://vl.genoma.io) and CTG-VIEW (https://view.genoma.io). Complete GWAS summary statistics and results from downstream analyses for all the chronic pain types reported in the current study (Supplementary Table S1) are available at CTG-VIEW.